A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients.
PHASE2
The primary objective:
-To assess the efficacy of TCH and TCHL in neo-adju...
Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
PHASE2
RATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, w...
Status
Completed
Location
Central Hematology Oncology Medical Group, Incorporated - Alhambra